Drug comparisons
Linagliptin vs Gliclazide
Compare Linagliptin (DPP-4 inhibitor) and Gliclazide (sulfonylurea) for type 2 diabetes. Differences in hypo risk, weight, and use in kidney disease.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting between a DPP-4 inhibitor and sulfonylurea for type 2 diabetes, particularly with hypoglycemia or renal concerns.
Bottom line
Linagliptin may suit those needing lower hypoglycemia risk or renal dosing flexibility, while Gliclazide can be effective and affordable for others.
All medication comparisons